Lowering ambient or core body temperature elevates striatal MPP + levels and enhances toxicity to dopamine neurons in MPTP-treated mice

Brain Research

Volumn 790, Issue 1-2, 1998, Pages 264-269

  Moy, Lily Y ^a   Albers, David S ^a,b   Sonsalla, Patricia K ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Core temperature; Dopamine; Methamphetamine; Mice; MPTP; Neurotoxicity; Striatum

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ARTICLE; CORE TEMPERATURE; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; HUMAN; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; THERMOREGULATION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 1-METHYL-4-PHENYLPYRIDINIUM; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BODY TEMPERATURE; CORPUS STRIATUM; DIZOCILPINE MALEATE; DOPAMINE; DOPAMINE AGENTS; EXCITATORY AMINO ACID ANTAGONISTS; METHAMPHETAMINE; MICE; MPTP POISONING; NERVE DEGENERATION; NEURONS; NEUROTOXINS; SEROTONIN AGONISTS; TYROSINE 3-MONOOXYGENASE;

EID: 0032550210     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00069-9     Document Type: Article

References (20)

1. D.S. Albers, P.K. Sonsalla, Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and non-protective agents, J. Pharmacol. Exp. Ther. 275 (1995) 1104-1114.
2. D.S. Albers, G.D. Zeevalk, P.K. Sonsalla, Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP, Brain Res. 718 (1996) 217-220.
3. J.F. Bowyer, A.W. Tank, G.D. Newport, W. Slikker Jr., S.F. Ali, R.R. Holson, The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in the rat striatum, J. Pharmacol. Exp. Ther. 260 (1992) 817-824.
4. J.F. Bowyer, D.L. Davies, L. Schmued, H.W. Broening, G.D. Newport, W. Slikker Jr., R.R. Holson, Further studies of the role of hyperthermia in methamphetamine toxicity, J. Pharmacol. Exp. Ther. 268 (1994) 1571-1580.
5. A. Buchan, W.A. Pulsinelli, Hypothermia but not the N-methyl-D-aspartate antagonist MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia, J. Neurosci. 10 (1990) 311-316.
6. R. Busto, W.D. Dietrich, M.Y.-T. Globus, I. Valdes, P. Scheinberg, M.D. Ginsberg, Small differences in intra-ischemic brain temperature critically determine the extent of ischemic neuronal injury, J. Cereb. Blood Flow Metab. 7 (1987) 729-738.
7. M. Cabanac, Temperature regulation, Annu. Rev. Physiol. 37 (1975) 415-439.
8. P. Chan, L.E. DeLanney, I. Irwin, J.W. Langston, D.A. Di Monte, Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse brain, J. Neurochem. 57 (1991) 348-351.
9. P. Chan, D.A. Di Monte, J.W. Langston, A.M. Janson, (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice, J. Pharmacol. Exp. Ther. 280 (1997) 439-446.
10. K. Chiba, A.J. Trevor, N. Castagnoli Jr., Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase, Biochem. Biophys. Res. Commun. 120 (1984) 574-578.
11. T.E. Freyaldenhoven, S.F. Ali, R.W. Hart, MPTP- and MPP+-induced effects on body temperature exhibit age- and strain-dependence in mice, Brain Res. 688 (1995) 161-170.
12. A. Giovanni, B.A. Sieber, R.E. Heikkila, P.K. Sonsalla, Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice, J. Pharmacol. Exp. Ther. 257 (1991) 691-697.
13. J.A. Javitch, R.J. D'Amato, S.M. Strittmatter, S.H. Snyder, Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity, Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 2173-2177.
14. S.P. Markey, J.N. Johannessen, C.C. Chiueh, R.S. Burns, M.A. Herkenham, Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism, Nature 311 (1984) 464-467.
15. D.B. Miller, J.P. O'Callaghan, Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse, J. Pharmacol. Exp. Ther. 270 (1994) 752-760.
16. H. Minamisawa, M.-L. Smith, B.K. Siesjo, The effect of mild hyperthermia and hypothermia on brain damage following 5, 10, and 15 minutes of forebrain ischemia, Ann. Neurol. 28 (1990) 26-33.
17. W.J. Nicklas, I. Vyas, R.E. Heikkila, Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, Life Sci. 36 (1985) 2503-2508.
18. N. Satoh, A. Yomezawa, T. Tadano, K. Kisara, Y. Arai, H. Kinemuchi, Acute effects of a parkinsonism-inducing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mouse body temperature, Life Sci. 41 (1987) 1415-1424.
19. P.K. Sonsalla, W.J. Nicklas, MPTP and Animal Models of Parkinson's Disease. in: W.C. Koller (Ed.), Handbook of Parkinson's Disease, Marcel Dekker, New York, 1992, pp. 319-340.
20. P.K. Sonsalla, D.E. Riordan, R.E. Heikkila, Competitive and non-competitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice, J. Pharmacol. Exp. Ther. 256 (1991) 506-512.